Table of Contents Hepatic Encephalopathy Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Hepatic Encephalopathy Therapeutics 1.1 Hepatic Encephalopathy Therapeutics Market Overview 1.1.1 Hepatic Encephalopathy Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Hepatic Encephalopathy Therapeutics Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Hepatic Encephalopathy Therapeutics Market by Type 1.3.1 Global Hepatic Encephalopathy Therapeutics Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Type in 2018 1.3.3 Kits 1.3.4 Reagents 1.3.5 Instruments 1.4 Hepatic Encephalopathy Therapeutics Market by End Users/Application 1.4.1 Acute Liver Failure 1.4.2 Portal Systemic Bypass without Liver Disease 1.4.3 Liver Cirrhosis 2 Global Hepatic Encephalopathy Therapeutics Competition Analysis by Players 2.1 Global Hepatic Encephalopathy Therapeutics Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 ASKA Pharmaceutical 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 COSMO Pharmaceuticals 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Fresenius Kabi 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Mallinckrodt Pharmaceuticals 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Lupin 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Salix Pharmaceuticals 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Teva Pharmaceutical 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Bausch Health 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Hepatic Encephalopathy Therapeutics Revenue (Value) (2014-2019) 3.8.5 Recent Developments 4 Global Hepatic Encephalopathy Therapeutics Market Size by Type and Application (2014-2019) 4.1 Global Hepatic Encephalopathy Therapeutics Market Size by Type (2014-2019) 4.2 Global Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) 4.3 Potential Application of Hepatic Encephalopathy Therapeutics in Future 4.4 Top Consumer/End Users of Hepatic Encephalopathy Therapeutics 5 North America Hepatic Encephalopathy Therapeutics Development Status and Outlook 5.1 North America Hepatic Encephalopathy Therapeutics Market Size (2014-2019) 5.2 North America Hepatic Encephalopathy Therapeutics Market Size and Market Share by Players (2014-2019) 5.3 North America Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) 6 Europe Hepatic Encephalopathy Therapeutics Development Status and Outlook 6.1 Europe Hepatic Encephalopathy Therapeutics Market Size (2014-2019) 6.2 Europe Hepatic Encephalopathy Therapeutics Market Size and Market Share by Players (2014-2019) 6.3 Europe Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) 7 China Hepatic Encephalopathy Therapeutics Development Status and Outlook 7.1 China Hepatic Encephalopathy Therapeutics Market Size (2014-2019) 7.2 China Hepatic Encephalopathy Therapeutics Market Size and Market Share by Players (2014-2019) 7.3 China Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) 8 Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Development Status and Outlook 8.1 Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size (2014-2019) 8.2 Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) 9 Central & South America Hepatic Encephalopathy Therapeutics Development Status and Outlook 9.1 Central & South America Hepatic Encephalopathy Therapeutics Market Size (2014-2019) 9.2 Central & South America Hepatic Encephalopathy Therapeutics Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) 10 Middle East & Africa Hepatic Encephalopathy Therapeutics Development Status and Outlook 10.1 Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size (2014-2019) 10.2 Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Hepatic Encephalopathy Therapeutics Market Size by Regions (2019-2025) 11.1.1 North America Hepatic Encephalopathy Therapeutics Revenue and Growth Rate (2019-2025) 11.1.2 Europe Hepatic Encephalopathy Therapeutics Revenue and Growth Rate (2019-2025) 11.1.3 China Hepatic Encephalopathy Therapeutics Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Hepatic Encephalopathy Therapeutics Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Hepatic Encephalopathy Therapeutics Revenue and Growth Rate (2019-2025) 11.2 Global Hepatic Encephalopathy Therapeutics Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Hepatic Encephalopathy Therapeutics Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Hepatic Encephalopathy Therapeutics Market Size (Million USD) Status and Outlook (2014-2025) Table Global Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Hepatic Encephalopathy Therapeutics Market Share by Regions (2014-2019) Figure North America Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure China Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Hepatic Encephalopathy Therapeutics Market Share by Type in 2018 & 2025 Figure Kits Market Size (Million USD) and Growth Rate (2014-2019) Figure Reagents Market Size (Million USD) and Growth Rate (2014-2019) Figure Instruments Market Size (Million USD) and Growth Rate (2014-2019) Table Global Hepatic Encephalopathy Therapeutics Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Hepatic Encephalopathy Therapeutics Market Share by Application in 2018 & 2025 Figure Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate in Acute Liver Failure (2014-2019) Figure Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate in Portal Systemic Bypass without Liver Disease (2014-2019) Figure Hepatic Encephalopathy Therapeutics Market Size (Million USD) and Growth Rate in Liver Cirrhosis (2014-2019) Table Global Hepatic Encephalopathy Therapeutics Revenue (Million US$) by Players (2014-2019) Table Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Players (2014-2019) Eigure Hepatic Encephalopathy Therapeutics Market Size Share by Players in 2018 Table Global Hepatic Encephalopathy Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Hepatic Encephalopathy Therapeutics Market Share in 2018 Figure Global Top 10 Players Hepatic Encephalopathy Therapeutics Market Share in 2018 Table Hepatic Encephalopathy Therapeutics Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table ASKA Pharmaceutical Basic Information List Table ASKA Pharmaceutical Description and Business Overview Table ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of ASKA Pharmaceutical (2014-2019) Table ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Recent Developments Table COSMO Pharmaceuticals Basic Information List Table COSMO Pharmaceuticals Description and Business Overview Table COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of COSMO Pharmaceuticals (2014-2019) Table COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Recent Developments Table Fresenius Kabi Basic Information List Table Fresenius Kabi Description and Business Overview Table Fresenius Kabi Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of Fresenius Kabi (2014-2019) Table Fresenius Kabi Hepatic Encephalopathy Therapeutics Recent Developments Table Mallinckrodt Pharmaceuticals Basic Information List Table Mallinckrodt Pharmaceuticals Description and Business Overview Table Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of Mallinckrodt Pharmaceuticals (2014-2019) Table Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Recent Developments Table Lupin Basic Information List Table Lupin Description and Business Overview Table Lupin Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of Lupin (2014-2019) Table Lupin Hepatic Encephalopathy Therapeutics Recent Developments Table Salix Pharmaceuticals Basic Information List Table Salix Pharmaceuticals Description and Business Overview Table Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of Salix Pharmaceuticals (2014-2019) Table Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Recent Developments Table Teva Pharmaceutical Basic Information List Table Teva Pharmaceutical Description and Business Overview Table Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of Teva Pharmaceutical (2014-2019) Table Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Recent Developments Table Bausch Health Basic Information List Table Bausch Health Description and Business Overview Table Bausch Health Hepatic Encephalopathy Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Hepatic Encephalopathy Therapeutics Business of Bausch Health (2014-2019) Table Bausch Health Hepatic Encephalopathy Therapeutics Recent Developments Table Global Hepatic Encephalopathy Therapeutics Market Size by Type (2014-2019) (Million US$) Figure Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Type in 2018 Table Global Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Global Hepatic Encephalopathy Therapeutics Revenue Market by Application in 2018 Table Top Consumer/End Users of Hepatic Encephalopathy Therapeutics Figure North America Hepatic Encephalopathy Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table North America Hepatic Encephalopathy Therapeutics Market Size by Players (2014-2019)(Million US$) Figure North America Hepatic Encephalopathy Therapeutics Market Size Share by Players in 2018 Table North America Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) (Million US$) Figure North America Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2014-2019) Figure North America Hepatic Encephalopathy Therapeutics Market Size Share by Application in 2018 Figure Europe Hepatic Encephalopathy Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Hepatic Encephalopathy Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Europe Hepatic Encephalopathy Therapeutics Market Size Share by Players in 2018 Table Europe Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Europe Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2014-2019) Figure Europe Hepatic Encephalopathy Therapeutics Market Size Share by Application in 2018 Figure China Hepatic Encephalopathy Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table China Hepatic Encephalopathy Therapeutics Market Size by Players (2014-2019)(Million US$) Figure China Hepatic Encephalopathy Therapeutics Market Size Share by Players in 2018 Table China Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) (Million US$) Figure China Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2014-2019) Figure China Hepatic Encephalopathy Therapeutics Market Size Share by Application in 2018 Figure Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size Share by Players in 2018 Table Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Market Size Share by Application in 2018 Figure Central & South America Hepatic Encephalopathy Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Hepatic Encephalopathy Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Central & South America Hepatic Encephalopathy Therapeutics Market Size Share by Players in 2018 Table Central & South America Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Central & South America Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2014-2019) Figure Central & South America Hepatic Encephalopathy Therapeutics Market Size Share by Application in 2018 Figure Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size Share by Players in 2018 Table Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size Share by Application in 2018 Figure Global Hepatic Encephalopathy Therapeutics Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Hepatic Encephalopathy Therapeutics Market Size by Regions (2019-2025) (Million US$) Figure Global Hepatic Encephalopathy Therapeutics Market Size Share by Regions (2019-2025) Figure Global Hepatic Encephalopathy Therapeutics Market Size Share by Regions in 2025 Figure North America Hepatic Encephalopathy Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Hepatic Encephalopathy Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure China Hepatic Encephalopathy Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Hepatic Encephalopathy Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Hepatic Encephalopathy Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Hepatic Encephalopathy Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Table Global Hepatic Encephalopathy Therapeutics Market Size by Application (2019-2025) (Million USD) Figure Global Hepatic Encephalopathy Therapeutics Market Size by Application (2019-2025) Figure Global Hepatic Encephalopathy Therapeutics Market Size by Application in 2025 Table Global Hepatic Encephalopathy Therapeutics Market Size by Type (2019-2025) (Million US$) Figure Global Hepatic Encephalopathy Therapeutics Market Size by Type (2019-2025) Figure Global Hepatic Encephalopathy Therapeutics Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

ASKA Pharmaceutical COSMO Pharmaceuticals Fresenius Kabi Mallinckrodt Pharmaceuticals Lupin Salix Pharmaceuticals Teva Pharmaceutical Bausch Health